On February 11th, we invited Professor Dohun Kwon, who is investigacióning TRPV1 structural analysis, to conduct a related seminario at our sede central.
Despite his busy schedule having just arrived from the United States, the seminario proporcionó an opportunity to discuss the latest investigación trends on TRPV1 and explore directions for colaboración on TRPV1 structural analysis investigación.
With many US empresas and investigadores recently reaching a consensus that TRPV1 is the ultimate target for analgésico no narcóticos, it was a valuable time to discuss the challenges and possibilities encountered in investigacióning many small molecules.
Basándose en esto meeting, both parties agreed to proceed with close colaboración on future investigación.
We would like to once again thank Professor Kwon for visiting RudaCure and look forward to meaningful investigación resultados in the future.
